Comparison of quality of life between 2-year and 3-or-more-year administration of leuprorelin acetate every-3-months depot in combination with tamoxifen as adjuvant endocrine treatment in premenopausal patients with endocrine-responsive breast cancer: a randomized controlled trial.
Support Care Cancer
; 26(3): 933-945, 2018 Mar.
Article
in En
| MEDLINE
| ID: mdl-29063390
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Quality of Life
/
Tamoxifen
/
Breast Neoplasms
/
Antineoplastic Combined Chemotherapy Protocols
/
Leuprolide
/
Chemotherapy, Adjuvant
Type of study:
Clinical_trials
/
Prognostic_studies
/
Qualitative_research
Aspects:
Patient_preference
Limits:
Adult
/
Female
/
Humans
/
Middle aged
Language:
En
Journal:
Support Care Cancer
Journal subject:
NEOPLASIAS
/
SERVICOS DE SAUDE
Year:
2018
Document type:
Article
Affiliation country:
Japón
Country of publication:
Alemania